CONTACT
+91 80 2808 2808
info@biocon.com

Biocon Biologics Receives MHRA, UK Approval for YESAFILI®, Biosimilar Aflibercept
  • Mon, 13-Nov-2023
  • Posted by: BIOCON
No Comments

Biocon Q2FY24 Revenue at Rs 3,620 Cr, Up 52%; Biosimilars Up 97%; Research Services Up 18% EBITDA at Rs 900 Cr, Up 68%; Core EBITDA at Rs 1,100 Cr, Up 35% Net Profit at Rs 126 Cr, Up 168%
  • Fri, 10-Nov-2023
  • Posted by: BIOCON
No Comments

EdelGive and Hurun India recognizes Kiran Mazumdar-Shaw as the Second most generous women philanthropist in India
  • Thu, 09-Nov-2023
  • Posted by: BIOCON
No Comments

Biocon Biologics Announces Divestment of Two Non-Core Branded Formulations – India Business Units
  • Wed, 08-Nov-2023
  • Posted by: BIOCON
No Comments

Biocon Ranked No. 8 Among Science Magazine’s Best Employers in Global Biotech and Pharma Sector
  • Tue, 31-Oct-2023
  • Posted by: BIOCON
No Comments

Kedar Upadhye Appointed as New CFO of Biocon Biologics Current CFO MB Chinappa to take on a Strategic Finance role at Biocon Group
  • Thu, 19-Oct-2023
  • Posted by: BIOCON
No Comments

Update on U.S. FDA Inspection at Biocon Biologics’ Manufacturing Facility in Johor, Malaysia
  • Wed, 18-Oct-2023
  • Posted by: BIOCON
No Comments

Biocon Biologics Receives Complete Response Letter from US FDA for Biosimilar Insulin Aspart
  • Sat, 07-Oct-2023
  • Posted by: BIOCON
No Comments

Biocon Limited signs commercialization agreement with Juno Pharmaceuticals in Canada
  • Fri, 06-Oct-2023
  • Posted by: BIOCON
No Comments

Biocon Biologics Receives European Commission Approval for YESAFILI®, Biosimilar Aflibercept
  • Wed, 20-Sep-2023
  • Posted by: BIOCON
No Comments

Report adverse event/ side effects and/or product complaints for Biocon products.


Click here to report adverse event/side effects/product complaints and/or submit medical queries for Biocon Biologics Limited & BBL Affiliate products.

Click here to report adverse event/side effects/product complaints and/or post medical queries for Biocon Limited, Biocon Pharma Limited, Biocon Pharma Inc., Biocon Pharma UK Limited, Biocon Pharma Malta Ltd and Biocon FZ LLC products.





* Safe Harbour | Privacy Policy | Terms of Use © 2024, Biocon. All Rights Reserved
Share
Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>